SRCAP Inhibitors

SRCAP inhibitors, as referred to here, are agents that modulate the activity of SRCAP, a chromatin remodeling protein involved in depositing histone variant H2A.Z into chromatin. Inhibitors of this protein's function are not necessarily direct binders of SRCAP, but rather are chemicals that impact the pathways and processes in which SRCAP is a critical component. The class of SRCAP inhibitors encompasses a variety of compounds, each having a distinct mechanism of action but converging on the alteration of chromatin dynamics and gene expression patterns.

These inhibitors affect SRCAP indirectly by modulating the epigenetic landscape. For instance, inhibitors of histone acetyltransferases and deacetylases change the acetylation state of histones, which in turn can affect the recruitment and activity of SRCAP in chromatin remodeling complexes. Other compounds, such as DNA methyltransferase inhibitors, alter methylation patterns on DNA, influencing the higher-order chromatin structure and potentially affecting SRCAP function. The overarching theme among these inhibitors is the perturbation of the epigenetic state, leading to altered chromatin architecture, which is essential for SRCAP's role in the regulation of gene expression.